Developer docs
API playgroundTry for free, no card

Search company profiles

La Roquette

Full company profile

uuid0009lq6

Namestring
La Roquette
Legal namestring
Roquette Frères
Websiteurl
roquette.com
Company typeenum
Private
Founded yearint
1933
Descriptiontext

Roquette Frères is a French, family-owned global leader in plant-based ingredients, founded in 1933 and headquartered in Lestrem, France. The company processes renewable raw materials — corn, wheat, potato, pea, rice, and fava bean — into specialty starches, native and modified (300+ grades), plant proteins (NUTRALYS pea, wheat, and fava isolates), soluble fibers (NUTRIOSE), polyols (NEOSORB, PEARLITOL, LYCADEX), cyclodextrins (KLEPTOSE), fermentation products (gluconic acid, GDL, succinic acid), and pharmaceutical excipients and APIs (METHOCEL HPMC, Qualicaps capsules, pyrogen-free parenteral-grade ingredients). Core technical capabilities include starch extraction and modification, protein isolation and texturization, fermentation, and biotransformation, underpinned by patented processes such as the AMYSTA thermally-induced soluble pea starch technology.

The company operates two business units — Nutrition & Bioindustry and Health & Pharma Solutions — serving B2B customers in food, nutrition, pharmaceutical, cosmetics, animal nutrition, and bioindustry end markets. Revenue is generated through direct enterprise sales with technical formulation support via Customer Technical Services (CTS) laboratories, complemented by selective channel partnerships (e.g., Barentz in US cosmetics, Rader in Italy) and long-term supply agreements with 5,000+ customers in 150+ countries. Roquette reported FY2025 turnover of €4.9 billion, employs 11,000+ people across 40+ manufacturing sites and 20+ R&D centers, and has materially scaled its pharmaceutical footprint through the 2023 acquisition of Qualicaps and the 2025 acquisition of IFF Pharma Solutions.

Short descriptiontext

Roquette Frères is a French, family-owned global leader in plant-based ingredients, producing starches, plant proteins, polyols, cyclodextrins, and pharmaceutical excipients for B2B customers across food, nutrition, pharma, cosmetics, and bioindustry in 150+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersBenifayó, Spain
HQ citystring
Benifayó
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices29 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
plant-based ingredients, pharmaceutical excipients, pea protein isolates, starch and polyols, cyclodextrin excipients
Industry3 codes
1Starches & Grain Derivatives Manufacturing (cornstarch, maltodextrin, glucose solids)
CodeAFAKABAGPrimaryYes
2Glucose Syrups & Dextrose (Corn/Wheat/Tapioca Glucose, Dextrose Monohydrate)
CodeAFAJAAADPrimaryNo
3Plant-Based Dairy-Alternative Ingredients & Bases Manufacturing (Emulsions, Fat Systems, Protein/Starch Bases for B2B)
CodeAFAHAJAIPrimaryNo
NAICS code2 codes
  • Starch and Vegetable Fats and Oils Manufacturing31122
  • Fats and Oils Refining and Blending311225
SIC code3 codes
  • Food And Kindred Products2000
  • Miscellaneous Food Preparations & Kindred Products2090
  • Fats & Oils2070
Product category
Specialty Plant-Based Ingredients
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Plant-Based Ingredients and Excipients
TypeOne Time License
Description

B2B sale of specialty ingredients including starches, proteins, fibers, polyols, cyclodextrins, fermentation products, and pharmaceutical excipients to food, nutrition, pharma, cosmetics, and bioindustry manufacturers. Revenue generated through long-term customer relationships (5,000+) with recurring product supply contracts.

roquette.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1NUTRALYS
Description

Plant protein brand including pea protein isolates and fava bean protein isolates for food and nutrition applications

vocal.media
+10 more records
Core offering1 text field

Roquette Frères is a global manufacturer of plant-based ingredients derived from corn, wheat, potato, pea, rice, and fava bean raw materials. The company supplies specialty starches, plant proteins, soluble fibers, polyols, cyclodextrins, fermentation products, and pharmaceutical excipients/APIs to industrial customers in food & nutrition, pharma, cosmetics, animal nutrition, agriscience, and bioindustry markets. Its offering is sold B2B to manufacturer clients through direct sales and selected regional distributors, supported by Customer Technical Services laboratories for formulation development.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Roquette Frères among key players controlling 58% of pea protein market supply globally
+1 more record
Product overview1 text field

La Roquette operates as a global leader in plant-based ingredients with two primary Business Units: Nutrition & Bioindustry and Health & Pharma Solutions. The product portfolio spans multiple categories including pharmaceutical APIs and excipients (injectables, oral dosage, capsules), food ingredients (plant proteins, fibers, starches, polyols, fermentation products), cosmetic ingredients (Beauté by Roquette®), and agriscience solutions. Key product lines include: NUTRALYS® pea and fava bean proteins, NUTRIOSE® soluble fiber, AMYSTA™ friendly-label starches, KLEPTOSE® cyclodextrins, PEARLITOL® and NEOSORB® polyols, METHOCEL™ HPMC, LYCAGEL® softgel systems, and Beauté by Roquette® cosmetic ingredients. Recent strategic acquisitions (IFF Pharma Solutions, Qualicaps) have significantly expanded the pharmaceutical capabilities. The company offers both physical ingredients and the HORIZONS digital platform for food industry strategic planning.

Product and service21 records
1NUTRALYS Pea Protein
CategoryFood Ingredient
Description

Comprehensive range of pea protein isolates and textured proteins for food applications including meat alternatives, dairy alternatives, sports nutrition, and specialized nutrition. Sold to food manufacturers.

2NUTRALYS Fava Protein
CategoryFood Ingredient
Description

Fava bean protein isolates including NUTRALYS Fava S900M, offering plant-based protein alternatives with sustainability benefits for food manufacturers.

3NUTRALYS Textured Wheat Protein
CategoryFood Ingredient
Description

Textured wheat protein range for meat alternative and food applications, sold to food manufacturers.

4NUTRIOSE Soluble Fiber
CategoryFood Ingredient
Description

Soluble fiber with clinically proven prebiotic health benefits, certified NutraStrong Prebiotic Verified, sold to food and nutraceutical manufacturers.

5AMYSTA Soluble Pea Starch
CategoryFood Ingredient
Description

Friendly-label soluble pea starch range using patented heat treatment process without enzymes or chemicals, declared as 'soluble pea starch' (EU) or 'pea starch' (USA), sold to clean-label food manufacturers.

6NEOSORB Sorbitol and Polyols
CategoryFood/Pharma Ingredient
Description

Polyol range used as sugar alternative in food products, pharmaceutical excipient for tablet manufacturing, active pharmaceutical ingredient for injectables, and sustainable alternative to petrochemicals.

7PEARLITOL Mannitol
CategoryFood/Pharma Ingredient
Description

Polyol serving as sugar alternative in food, pharmaceutical excipient, and active pharmaceutical ingredient for various applications.

8LYCADEX PF Dextrose Monohydrate
CategoryPharmaceutical API/Excipient
Description

Pyrogen-free carbohydrate source widely used in parenteral preparations including large volume parenterals (LVP) and total parenteral nutrition (TPN), also serving as osmotic agent for dialysis applications. Sold to pharmaceutical manufacturers.

9PEARLITOL PF Mannitol
CategoryPharmaceutical API/Excipient
Description

Pyrogen-free mannitol serving as both API (osmotic diuretic agent) and excipient (isotonic agent, bulking agent for freeze-dried injectable powders). Sold to pharmaceutical manufacturers.

10NEOSORB PF Sorbitol
CategoryPharmaceutical API/Excipient
Description

Pyrogen-free API suitable for parenteral applications including irrigation fluids, offering high solubility and stability. Sold to pharmaceutical manufacturers.

11Sodium Gluconate Pharma
CategoryPharmaceutical API/Excipient
Description

Highly purified organic salt used in injectable preparations and dialysis solutions as physiological electrolyte agent (API) and buffer agent (excipient). Sold to pharmaceutical manufacturers.

12KLEPTOSE Hydroxypropyl Beta-Cyclodextrin
CategoryPharmaceutical Excipient
Description

Parenteral-grade cyclodextrin excipients for solubilizing and stabilizing APIs, helping reduce injection site irritation and maintaining stability under sterilization conditions. Sold to pharmaceutical manufacturers.

13Isosorbide C Pharma
CategoryPharmaceutical API
Description

Specialty API for oral administration that expands formulation options with high quality standards, bridging parenteral and oral administration capabilities. Sold to pharmaceutical manufacturers.

14Qualicaps Pharmaceutical Capsules
CategoryPharmaceutical Excipient
Description

Hard capsule solutions for pharmaceutical and nutraceutical applications, part of expanded portfolio following IFF Pharma Solutions acquisition. Sold to pharmaceutical and nutraceutical manufacturers.

15METHOCEL HPMC
CategoryPharmaceutical Excipient
Description

Hydroxypropyl methylcellulose products for controlled release, binding, and film-forming in pharmaceutical formulations. Award-winning low nitrite version available. Sold to pharmaceutical manufacturers.

16LYCAGEL Softgel Excipient
CategoryPharmaceutical/Nutraceutical Excipient
Description

Hydroxypropyl pea starch premix for softgel capsules including LYCAGEL Premix (ready-to-use) and LYCAGEL Flex (new formulation). Sold to pharmaceutical and nutraceutical manufacturers.

17BIOSUCCINIUM Bio-Succinic Acid
CategoryBioindustry Ingredient
Description

Bio-based succinic acid for biodegradable plastics, packaging, and industrial applications, ISCC PLUS certified. Sold to industrial manufacturers.

18Fermentation Products (Gluconic Acid, GDL, Succinic Acid)
CategoryFood/Pharma/Bioindustry Ingredient
Description

Organic acids and derivatives including gluconic acid, glucono-delta-lactone (GDL), sodium gluconate, and succinic acid derived from renewable corn feedstock. Sold to food, pharmaceutical, and industrial manufacturers.

19Beauté by Roquette Cosmetic Ingredients
CategoryCosmetic Ingredient
Description

Plant-based cosmetic ingredients for skin care, hair care, oral care, and color cosmetics, including film formers, thickeners, sensory powders, alginates, and preservation boosters. Sold to cosmetics manufacturers.

20HORIZONS Platform
CategoryDigital/Consulting Service
Description

Prospective platform using AI-based advanced analysis to help food industry companies anticipate change, explore future possibilities, and convert uncertainty into concrete strategies.

21NEOSORB AG Agriscience Polyols
CategoryAgriscience Product
Description

Plant-based multifunctional polyol range developed for sustainable agriculture formulations including crop protection, growth enhancement, and regenerative agriculture programs. Sold to agriscience formulators.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-03-28
Description

Multi-year pea protein supply agreement committing approximately $23.5 million for 2026-2027. Secures pea protein supply for Beyond Meat's plant-based meat alternative production, representing about 8.5% of Beyond Meat's trailing twelve-month revenue.

Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-05-01
Description

Acquisition completed May 2025, making Roquette a reference player in oral drug delivery solutions globally. Combined portfolio includes excipients, capsules, APIs, and drug delivery technologies.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2024-07-08
Description

Cooperation agreement to support Tagatose growth - a natural sweetener with clinically proven health benefits. Roquette providing manufacturing and commercial support.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-04-23
Description

Exclusive distributor for Roquette Beauté cosmetic ingredients in the United States. Barentz is a leading global life science ingredients distributor.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-03-05
Description

Sole distributor for Roquette's plant-based food ingredients in Italy, covering all of Italy after expanding to southern regions.

Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2023-10-24
Description

Acquisition completed October 2023, strengthening Roquette's global position in pharmaceutical hard capsules for oral dosage forms.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Joined VIVESCIA's TRANSITIONS program for regenerative agriculture. Supports soil health improvement, carbon emission reduction, and biodiversity protection in sustainable food supply chains.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Joined the For Living Agriculture movement participating in COVALO Hauts-de-France territorial coalition and the 1st Regenerative Environmental Payment program.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

US regenerative agriculture partnership supporting soil health, carbon reduction, and biodiversity protection through farmer engagement programs.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

US-based specialist in plant proteins (pea, rice, hemp) and dairy alternatives. Smaller and more focused than Roquette but directly competes in the pea protein isolate market NUTRALYS® leads.

TypeDirect peer
Description

Irish-listed nutrition solutions provider with plant-based and dairy protein portfolios for food, beverage, and supplements. Comparable B2B ingredient model with overlap in protein ingredients and sports/performance nutrition.

TypeDirect peer
Description

US-listed corn refiner producing native and modified starches, sweeteners, and nutrition ingredients. Directly comparable starch and sweetener portfolio targeting food, beverage, and nutrition manufacturers globally.

TypeBroad incumbent
Description

Private global agribusiness giant with significant plant protein and ingredient operations. Overlaps with Roquette in specialty proteins and food ingredients while operating much broader commodity and animal nutrition businesses.

TypeDirect peer
Description

Subsidiary of Südzucker producing functional ingredients including rice/pea proteins, prebiotic fibers, and specialty carbohydrates. Directly competes with Roquette in clean-label plant proteins and soluble fibers.

TypeBroad incumbent
Description

Global agricultural processor and one of the top 4 protein ingredient producers alongside Roquette. Competes across plant proteins, starches, and fermentation products, with broader commodity trading and animal nutrition reach.

TypeDirect peer
Description

Irish-listed taste and nutrition company supplying food and beverage manufacturers. Comparable B2B ingredients model with overlapping customer base and similar clean-label, plant-based positioning.

TypeBroad incumbent
Description

Post-divestiture of Pharma Solutions (acquired by Roquette in 2025), IFF retains food ingredients and flavors capabilities. Comparable position in food and nutrition B2B ingredients, with overlapping customer base.

TypeDirect peer
Description

Dutch-listed ingredients company specializing in lactic acid, preservation, and functional ingredient blends for food and bioindustry. Comparable fermentation-based ingredient portfolio serving food and industrial customers.

TypeDirect peer
Description

UK-listed specialty food ingredients company focused on starches, sweeteners, and texturants for food and beverage. Closely aligned product mix and customer base with Roquette's Food & Nutrition business.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries17 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

La Roquette

Specialty Plant-Based Ingredientsroquette.com

Roquette Frères is a French, family-owned global leader in plant-based ingredients, producing starches, plant proteins, polyols, cyclodextrins, and pharmaceutical excipients for B2B customers across food, nutrition, pharma, cosmetics, and bioindustry in 150+ countries.

What La Roquette does

Roquette Frères is a French, family-owned global leader in plant-based ingredients, founded in 1933 and headquartered in Lestrem, France. The company processes renewable raw materials — corn, wheat, potato, pea, rice, and fava bean — into specialty starches, native and modified (300+ grades), plant proteins (NUTRALYS pea, wheat, and fava isolates), soluble fibers (NUTRIOSE), polyols (NEOSORB, PEARLITOL, LYCADEX), cyclodextrins (KLEPTOSE), fermentation products (gluconic acid, GDL, succinic acid), and pharmaceutical excipients and APIs (METHOCEL HPMC, Qualicaps capsules, pyrogen-free parenteral-grade ingredients). Core technical capabilities include starch extraction and modification, protein isolation and texturization, fermentation, and biotransformation, underpinned by patented processes such as the AMYSTA thermally-induced soluble pea starch technology.

The company operates two business units — Nutrition & Bioindustry and Health & Pharma Solutions — serving B2B customers in food, nutrition, pharmaceutical, cosmetics, animal nutrition, and bioindustry end markets. Revenue is generated through direct enterprise sales with technical formulation support via Customer Technical Services (CTS) laboratories, complemented by selective channel partnerships (e.g., Barentz in US cosmetics, Rader in Italy) and long-term supply agreements with 5,000+ customers in 150+ countries. Roquette reported FY2025 turnover of €4.9 billion, employs 11,000+ people across 40+ manufacturing sites and 20+ R&D centers, and has materially scaled its pharmaceutical footprint through the 2023 acquisition of Qualicaps and the 2025 acquisition of IFF Pharma Solutions.

La Roquette firmographics

Firmographics
Name
La Roquette
Legal name
Roquette Frères
Website
https://roquette.com
Company type
Private
Founded year
1933
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Roquette Frères is a French, family-owned global leader in plant-based ingredients, producing starches, plant proteins, polyols, cyclodextrins, and pharmaceutical excipients for B2B customers across food, nutrition, pharma, cosmetics, and bioindustry in 150+ countries.
Ownership category
akta.pro rank

La Roquette industry classification

Industry
Product category
Specialty Plant-Based Ingredients
NAICS
Starch and Vegetable Fats and Oils Manufacturing (31122), Fats and Oils Refining and Blending (311225)
SIC
Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090), Fats & Oils (2070)
akta.pro primary industry
Starches & Grain Derivatives Manufacturing (cornstarch, maltodextrin, glucose solids) (AFAKABAG)
akta.pro secondary industries
Glucose Syrups & Dextrose (Corn/Wheat/Tapioca Glucose, Dextrose Monohydrate) (AFAJAAAD), Plant-Based Dairy-Alternative Ingredients & Bases Manufacturing (Emulsions, Fat Systems, Protein/Starch Bases for B2B) (AFAHAJAI)

Keywords

  • Plant-based ingredients
  • Pharmaceutical excipients
  • Pea protein isolates
  • Starch and polyols
  • Cyclodextrin excipients

Where La Roquette is headquartered

Location

Headquarters

HQ city
Benifayó
HQ country
Spain
HQ region
Europe

Offices29 records

Markets served

La Roquette business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Plant-Based Ingredients and Excipients: B2B sale of specialty ingredients including starches, proteins, fibers, polyols, cyclodextrins, fermentation products, and pharmaceutical excipients to food, nutrition, pharma, cosmetics, and bioindustry manufacturers. Revenue generated through long-term customer relationships (5,000+) with recurring product supply contracts.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

La Roquette product offering

Product offering

Core offering

Roquette Frères is a global manufacturer of plant-based ingredients derived from corn, wheat, potato, pea, rice, and fava bean raw materials. The company supplies specialty starches, plant proteins, soluble fibers, polyols, cyclodextrins, fermentation products, and pharmaceutical excipients/APIs to industrial customers in food & nutrition, pharma, cosmetics, animal nutrition, agriscience, and bioindustry markets. Its offering is sold B2B to manufacturer clients through direct sales and selected regional distributors, supported by Customer Technical Services laboratories for formulation development.

Product overview

La Roquette operates as a global leader in plant-based ingredients with two primary Business Units: Nutrition & Bioindustry and Health & Pharma Solutions. The product portfolio spans multiple categories including pharmaceutical APIs and excipients (injectables, oral dosage, capsules), food ingredients (plant proteins, fibers, starches, polyols, fermentation products), cosmetic ingredients (Beauté by Roquette®), and agriscience solutions. Key product lines include: NUTRALYS® pea and fava bean proteins, NUTRIOSE® soluble fiber, AMYSTA™ friendly-label starches, KLEPTOSE® cyclodextrins, PEARLITOL® and NEOSORB® polyols, METHOCEL™ HPMC, LYCAGEL® softgel systems, and Beauté by Roquette® cosmetic ingredients. Recent strategic acquisitions (IFF Pharma Solutions, Qualicaps) have significantly expanded the pharmaceutical capabilities. The company offers both physical ingredients and the HORIZONS digital platform for food industry strategic planning.

Differentiator

Problem solved

Functional benefit

Brands

  • NUTRALYS: Plant protein brand including pea protein isolates and fava bean protein isolates for food and nutrition applications
  • AMYSTA
  • Beauté by Roquette
  • CLEARAM
  • NEOSORB
  • PEARLITOL
  • LYCADEX
  • KLEPTOSE
  • LYCAGEL
  • Roquette Beauté
  • Roquette Ventures

Products and services

  • NUTRALYS Pea Protein Comprehensive range of pea protein isolates and textured proteins for food applications including meat alternatives, dairy alternatives, sports nutrition, and specialized nutrition. Sold to food manufacturers.
  • NUTRALYS Fava Protein Fava bean protein isolates including NUTRALYS Fava S900M, offering plant-based protein alternatives with sustainability benefits for food manufacturers.
  • NUTRALYS Textured Wheat Protein Textured wheat protein range for meat alternative and food applications, sold to food manufacturers.
  • NUTRIOSE Soluble Fiber Soluble fiber with clinically proven prebiotic health benefits, certified NutraStrong Prebiotic Verified, sold to food and nutraceutical manufacturers.
  • AMYSTA Soluble Pea Starch Friendly-label soluble pea starch range using patented heat treatment process without enzymes or chemicals, declared as 'soluble pea starch' (EU) or 'pea starch' (USA), sold to clean-label food manufacturers.
  • NEOSORB Sorbitol and Polyols Polyol range used as sugar alternative in food products, pharmaceutical excipient for tablet manufacturing, active pharmaceutical ingredient for injectables, and sustainable alternative to petrochemicals.
  • PEARLITOL Mannitol Polyol serving as sugar alternative in food, pharmaceutical excipient, and active pharmaceutical ingredient for various applications.
  • LYCADEX PF Dextrose Monohydrate Pyrogen-free carbohydrate source widely used in parenteral preparations including large volume parenterals (LVP) and total parenteral nutrition (TPN), also serving as osmotic agent for dialysis applications. Sold to pharmaceutical manufacturers.
  • PEARLITOL PF Mannitol Pyrogen-free mannitol serving as both API (osmotic diuretic agent) and excipient (isotonic agent, bulking agent for freeze-dried injectable powders). Sold to pharmaceutical manufacturers.
  • NEOSORB PF Sorbitol Pyrogen-free API suitable for parenteral applications including irrigation fluids, offering high solubility and stability. Sold to pharmaceutical manufacturers.
  • Sodium Gluconate Pharma Highly purified organic salt used in injectable preparations and dialysis solutions as physiological electrolyte agent (API) and buffer agent (excipient). Sold to pharmaceutical manufacturers.
  • KLEPTOSE Hydroxypropyl Beta-Cyclodextrin Parenteral-grade cyclodextrin excipients for solubilizing and stabilizing APIs, helping reduce injection site irritation and maintaining stability under sterilization conditions. Sold to pharmaceutical manufacturers.
  • Isosorbide C Pharma Specialty API for oral administration that expands formulation options with high quality standards, bridging parenteral and oral administration capabilities. Sold to pharmaceutical manufacturers.
  • Qualicaps Pharmaceutical Capsules Hard capsule solutions for pharmaceutical and nutraceutical applications, part of expanded portfolio following IFF Pharma Solutions acquisition. Sold to pharmaceutical and nutraceutical manufacturers.
  • METHOCEL HPMC Hydroxypropyl methylcellulose products for controlled release, binding, and film-forming in pharmaceutical formulations. Award-winning low nitrite version available. Sold to pharmaceutical manufacturers.
  • LYCAGEL Softgel Excipient Hydroxypropyl pea starch premix for softgel capsules including LYCAGEL Premix (ready-to-use) and LYCAGEL Flex (new formulation). Sold to pharmaceutical and nutraceutical manufacturers.
  • BIOSUCCINIUM Bio-Succinic Acid Bio-based succinic acid for biodegradable plastics, packaging, and industrial applications, ISCC PLUS certified. Sold to industrial manufacturers.
  • Fermentation Products (Gluconic Acid, GDL, Succinic Acid) Organic acids and derivatives including gluconic acid, glucono-delta-lactone (GDL), sodium gluconate, and succinic acid derived from renewable corn feedstock. Sold to food, pharmaceutical, and industrial manufacturers.
  • Beauté by Roquette Cosmetic Ingredients Plant-based cosmetic ingredients for skin care, hair care, oral care, and color cosmetics, including film formers, thickeners, sensory powders, alginates, and preservation boosters. Sold to cosmetics manufacturers.
  • HORIZONS Platform Prospective platform using AI-based advanced analysis to help food industry companies anticipate change, explore future possibilities, and convert uncertainty into concrete strategies.
  • NEOSORB AG Agriscience Polyols Plant-based multifunctional polyol range developed for sustainable agriculture formulations including crop protection, growth enhancement, and regenerative agriculture programs. Sold to agriscience formulators.

Quantifiable outcome

  • Roquette Frères among key players controlling 58% of pea protein market supply globally
  • +1 more outcomes

Companies that use La Roquette

Customer profile

Named customers1 record

Segments6 records

Ideal customer profiles4 records

La Roquette technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

La Roquette partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered major, flagship, strategic and core.

  • Beyond MeatmajorStrategic or Co-development Partner · 28 March 2026Multi-year pea protein supply agreement committing approximately $23.5 million for 2026-2027. Secures pea protein supply for Beyond Meat's plant-based meat alternative production, representing about 8.5% of Beyond Meat's trailing twelve-month revenue.
  • IFF Pharma SolutionsflagshipOEM/ Whitelabel/ Licensing Partner · 1 May 2025Acquisition completed May 2025, making Roquette a reference player in oral drug delivery solutions globally. Combined portfolio includes excipients, capsules, APIs, and drug delivery technologies.
  • BonumosestrategicStrategic or Co-development Partner · 8 July 2024Cooperation agreement to support Tagatose growth - a natural sweetener with clinically proven health benefits. Roquette providing manufacturing and commercial support.
  • BarentzcoreChannel Partner/ Reseller/ Distributor · 23 April 2024Exclusive distributor for Roquette Beauté cosmetic ingredients in the United States. Barentz is a leading global life science ingredients distributor.
  • RadercoreChannel Partner/ Reseller/ Distributor · 5 March 2024Sole distributor for Roquette's plant-based food ingredients in Italy, covering all of Italy after expanding to southern regions.
  • QualicapsflagshipOEM/ Whitelabel/ Licensing Partner · 24 October 2023Acquisition completed October 2023, strengthening Roquette's global position in pharmaceutical hard capsules for oral dosage forms.
  • VIVESCIAcoreStrategic or Co-development Partner · 1 January 2023Joined VIVESCIA's TRANSITIONS program for regenerative agriculture. Supports soil health improvement, carbon emission reduction, and biodiversity protection in sustainable food supply chains.
  • Pour une Agriculture du Vivant (PADV)coreStrategic or Co-development Partner · 1 January 2023Joined the For Living Agriculture movement participating in COVALO Hauts-de-France territorial coalition and the 1st Regenerative Environmental Payment program.
  • TruterracoreStrategic or Co-development Partner · 1 January 2023US regenerative agriculture partnership supporting soil health, carbon reduction, and biodiversity protection through farmer engagement programs.

Scale indicators10 records

Recent moves10 records

Expansion highlights6 records

La Roquette competitors and assessment

Company assessment

Emerging players

  • Axiom Foods: US-based specialist in plant proteins (pea, rice, hemp) and dairy alternatives. Smaller and more focused than Roquette but directly competes in the pea protein isolate market NUTRALYS® leads.

Direct peers

  • Glanbia Nutritionals: Irish-listed nutrition solutions provider with plant-based and dairy protein portfolios for food, beverage, and supplements. Comparable B2B ingredient model with overlap in protein ingredients and sports/performance nutrition.
  • Ingredion Incorporated: US-listed corn refiner producing native and modified starches, sweeteners, and nutrition ingredients. Directly comparable starch and sweetener portfolio targeting food, beverage, and nutrition manufacturers globally.
  • BENEO (Südzucker Group): Subsidiary of Südzucker producing functional ingredients including rice/pea proteins, prebiotic fibers, and specialty carbohydrates. Directly competes with Roquette in clean-label plant proteins and soluble fibers.
  • Kerry Group: Irish-listed taste and nutrition company supplying food and beverage manufacturers. Comparable B2B ingredients model with overlapping customer base and similar clean-label, plant-based positioning.
  • Corbion: Dutch-listed ingredients company specializing in lactic acid, preservation, and functional ingredient blends for food and bioindustry. Comparable fermentation-based ingredient portfolio serving food and industrial customers.
  • Tate & Lyle: UK-listed specialty food ingredients company focused on starches, sweeteners, and texturants for food and beverage. Closely aligned product mix and customer base with Roquette's Food & Nutrition business.

Broad incumbents

  • Cargill: Private global agribusiness giant with significant plant protein and ingredient operations. Overlaps with Roquette in specialty proteins and food ingredients while operating much broader commodity and animal nutrition businesses.
  • ADM (Archer Daniels Midland): Global agricultural processor and one of the top 4 protein ingredient producers alongside Roquette. Competes across plant proteins, starches, and fermentation products, with broader commodity trading and animal nutrition reach.
  • IFF (International Flavors & Fragrances): Post-divestiture of Pharma Solutions (acquired by Roquette in 2025), IFF retains food ingredients and flavors capabilities. Comparable position in food and nutrition B2B ingredients, with overlapping customer base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

La Roquette social profiles

Digital presence

La Roquette compliance and trust

Trust signal

Compliance10 records

La Roquette financial estimates

Financial estimate

Revenue estimate

Valuation estimate

La Roquette leadership team

Management profile

Number of profiles

Profiles8 records

La Roquette subsidiaries and ownership

Company hierarchy

Subsidiaries17 records

La Roquette funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

La Roquette M&A and investment

M&A and investment

M&A2 records

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about La Roquette

What does La Roquette do?

Roquette Frères is a global manufacturer of plant-based ingredients derived from corn, wheat, potato, pea, rice, and fava bean raw materials. The company supplies specialty starches, plant proteins, soluble fibers, polyols, cyclodextrins, fermentation products, and pharmaceutical excipients/APIs to industrial customers in food & nutrition, pharma, cosmetics, animal nutrition, agriscience, and bioindustry markets. Its offering is sold B2B to manufacturer clients through direct sales and selected regional distributors, supported by Customer Technical Services laboratories for formulation development.

Is La Roquette a public or private company?

La Roquette is a private company. It is classified as family owned and is currently operating.

When was La Roquette founded?

La Roquette was founded in 1933. It employs 5,001 to 10,000 people.

Where is La Roquette based?

La Roquette is headquartered in Benifayó, Spain, in the Europe region.

How does La Roquette make money?

One revenue line is on record: plant-Based Ingredients and Excipients.

Who are La Roquette's main competitors?

Axiom Foods is listed as an emerging player. Direct peers are Glanbia Nutritionals, Ingredion Incorporated, BENEO (Südzucker Group), Kerry Group, Corbion and Tate & Lyle. Broad incumbents are Cargill, ADM (Archer Daniels Midland) and IFF (International Flavors & Fragrances).

Does La Roquette have an API?

No public API is recorded for La Roquette.

What industry is La Roquette in?

La Roquette's product category is Specialty Plant-Based Ingredients. Its primary akta.pro industry code is AFAKABAG, Starches & Grain Derivatives Manufacturing (cornstarch, maltodextrin, glucose solids), with a secondary code of AFAJAAAD, Glucose Syrups & Dextrose (Corn/Wheat/Tapioca Glucose, Dextrose Monohydrate). Its NAICS code is 31122 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Les Echos« Nous faisons face à des difficultés qui deviennent structurelles » : les amidonniers, thermomètre de l'agroalimentaire, forcés de se réinventerAmidoniers supply starch to agro-industrial clients, whose orders reflect sector health. In 2025, these clients accounted for 59% of amidonniers' French sales, up 5.4% proportionally. The four majors—ADM, Cargill, Roquette, and Tereos—are represented by the Usipa syndicate.The Times of IndiaKarnataka woos French companies for investments in manufacturing, R&D and aerospace sectorsKarnataka's delegation met French firms Roquette, bioMérieux, and Hutchinson in France and the Netherlands, discussing manufacturing, R&D, and aerospace investments. Roquette was encouraged to expand its Gokak facility, bioMérieux to explore a development centre, and Hutchinson to invest in automotive and aerospace sectors.EIN PresswireMicrocrystalline Cellulose Market to Grow from USD 1.54 Billion in 2026 to USD 2.72 Billion by 2035 at 6.85% CAGRThe global microcrystalline cellulose market is projected to grow from $1.54 billion in 2026 to $2.72 billion by 2035, a 6.85% CAGR. Asia-Pacific leads with 40.12% revenue share, and pharmaceuticals account for 46.10% of 2025 revenue. Process shifts toward steam explosion and non-wood feedstocks are noted.PrtimesBinders and Scaffolders for Meat & Meat Substitutes Market to Hit US$ 3.33 Billion by 2034 – PR TimesThe global market for binders and scaffolders used in meat and meat substitutes is projected to grow from US$ 1.73 billion in 2025 to US$ 3.33 billion by 2034, driven by demand for texture improvement in plant-based products and structural support for cultured meat. Key industry players including Kerry, Ingredion, Roquette Freres, and specialized firms like Matrix Meats are developing sustainable, plant-derived ingredients to meet clean-label trends and reduce production costs. Regional growth is led by North America and Europe, with Asia Pacific expanding rapidly due to rising processed meat consumption and government-backed food innovation programs.Les EchosLe groupe Roquette, le roi français de l'amidon, pourrait ouvrir son capital au fonds CVCThe Roquette family, which holds 100% ownership of the French starch manufacturer Roquette, has entered preliminary discussions with European investment fund CVC Capital Partners to potentially sell a minority stake in the company. The family initiated this process earlier this year, engaging BNP Paribas and Rothschild & Co as advisory banks to manage the potential transaction. This would mark the first time the historically independent, family-owned group opens its capital since its founding in Lestrem, Pas-de-Calais.24-7 Press ReleaseSustained Release Polymers Market Advances as Drug Delivery Innovation Reshapes Pharmaceutical Formulation Strategies with USD 7.8 Billion in 2036The global sustained release polymers market is projected to grow from USD 3.8 billion in 2026 to USD 7.8 billion by 2036, a CAGR of 7.4%. Cellulose derivatives and matrix systems lead segments, with Asia as the fastest-growing region. Growth is driven by chronic disease demand and regulatory emphasis on excipient documentation.EIN PresswireWheat Protein Market Set for Steady Growth as Demand for Plant-Based Nutrition AcceleratesThe global wheat protein market is projected to grow from US$3.8 billion in 2026 to US$5.5 billion by 2033, a 5.4% CAGR. Europe held the largest share at 37.6% in 2025, with North America and Asia Pacific expected to drive future expansion. Rising demand for plant-based and high-protein foods supports steady growth.EIN PresswireWhat Strategies Are Companies Using in the Xylitol MarketRoquette Freres SA led global xylitol sales in 2024 with a 2% market share, while the top 10 players held 15% of total revenue. The market is fragmented, with leading companies including Cargill, Ingredion, and ADM. Strategic partnerships and product innovation are expected to strengthen major players' positions.GlobeNewswireRoquette Successfully Prices its Hybrid Notes Issuance forRoquette priced EUR 600 million perpetual hybrid subordinated notes with a fixed rate of 6% until 21 April 2032. The offering was oversubscribed 4.7 times, with a final orderbook above EUR 2.8 billion. Proceeds will be used for general corporate purposes.openPR.comDextrose Monohydrate Market: In-Depth Insights, Business Opportunities, and Top Companies Analysis Forecast by 2033 | Ingredion • Roquette Frères • Tate & Lyle • Merck KGaAThe article reports on the market analysis of Dextrose Monohydrate, with a forecast through 2033, highlighting key companies involved such as Ingredion, Roquette Frères, Tate & Lyle, and Merck KGaA. It discusses market segmentation into sectors like pharmaceuticals, food and beverages, and biotechnology.